| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06457425 A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk… |
Enrollment closed, study ongoing |
| 2026-08-13 | NCT06457425 A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk… |
date change Primary completion moved earlier: 2026-05-06 -> 2025-11-26 |
| 2026-08-13 | NCT06457425 A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk… |
date change Completion pushed: 2026-07-06 -> 2027-05-12 |
| 2026-08-11 | NCT07612306 Mass Balance Study of [14C] Flonoltinib Maleate |
Completed without a posted recruiting period |
| 2026-08-11 | NCT07612306 Mass Balance Study of [14C] Flonoltinib Maleate |
date change Primary completion moved earlier: 2026-10-30 -> 2026-07-25 |
| 2026-08-11 | NCT07612306 Mass Balance Study of [14C] Flonoltinib Maleate |
date change Completion moved earlier: 2026-12-30 -> 2026-07-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07757152 Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China | Phase 1 | Recruiting |
| 2026-08-06 | NCT07750574 Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07011056 | A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse… | Recurrent and Refractory Diffuse Large B-cell Lymphoma | Recruiting |
| NCT07317700 | A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis | MF | Recruiting |
| Phase 2 | |||
| NCT07193589 | A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis | Atopic Dermatitis | Recruiting |
| NCT07443306 | A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor… | MF | Recruiting |
| NCT07232290 | Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With… | Polycythemia Vera (PV) | Recruiting |
| NCT05563844 | Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory… | Diffuse Large B Cell Lymphoma，DLBCL | Active, Not Recruiting |
| NCT06485219 | A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With… | Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | Active, Not Recruiting |
| NCT07750574 | Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis | Myelofibrosis | Not Yet Recruiting |
| NCT06457425 | A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk… | MF,PMF,PPV-MF,PET-MF | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06484829 | Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in… | Relapsed or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT06431243 | A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid… | Advanced Solid Tumor | Recruiting |
| NCT07339748 | A Clinical Study of ZL-85FA Tablets | Advanced Solid Tumor | Not Yet Recruiting |
| Phase 1 | |||
| NCT07757152 | Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China | Healthy Participants Study | Recruiting |